DocGo (DCGOW) Research & Development: $13.63 Mil (TTM As of Mar. 2026)


DCGOW DocGo Inc DCGOW
60 GF Score
Price $1.96
! 5 Warning Signs
View Full Analysis

What is DocGo Research & Development?

DocGo DCGOW 60 Research & Development is $13.63 Mil as of Mar. 2026. GuruFocus rates DCGOW with a GF Score™ of 60/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. DocGo's Research & Development for the three months ended in Mar. 2026 was $3.71 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $13.63 Mil.

DocGo  (NAS:DCGOW) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

DocGo Research & Development Related Terms

DocGo Research & Development Historical Data

* Premium members only.

The historical data trend for DocGo's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DocGo Research & Development Chart

DocGo Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 3.32 5.39 10.86 11.59 13.56

DocGo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 2.96 3.19 3.77 3.71
DCGOW
60GF Score
DocGo Inc DCGOW
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DocGo Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $13.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $13.63 Mil mean?
DocGo (DCGOW) has a Research & Development of $13.63 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on DocGo and its competitors.
Is DocGo's Research & Development too high?
DocGo's current Research & Development is $13.63 Mil. Overall, DocGo has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does DocGo's Research & Development compare to BTMD and PIII?
DocGo's Research & Development of $13.63 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on DocGo and its competitors. DocGo's current Research & Development is $13.63 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocGo stock overvalued right now?
DocGo (DCGOW) has a current Research & Development of $13.63 Mil. The current Research & Development is $13.63 Mil. DocGo's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For DocGo (DCGOW), the current Research & Development is $13.63 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DocGo Business Description

Other Exchanges DCGO:USA
Address 685 Third Avenue, 9th Floor, New York, NY, USA, 10017
DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.
60GF Score

Get the complete analysis for DCGOW

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.96
Price